ID   WAe009-A-W
AC   CVCL_D6K5
SY   H9 NGN2 B6; UOWe010-A-W
DR   BioSamples; SAMEA114312888
DR   hPSCreg; WAe009-A-W
DR   Wikidata; Q127384686
RX   PubMed=38244534;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Characteristics: Using CRISPR/Cas9 a stably integrated doxycycline-inducible NEUROG2/NGN2 construct (LoxP-EF1A-Bsd-mApple-LoxP-CAG-rtTA3G-NEUROG2-TRe3G was introduced in the CLYBL locus (PubMed=38244534).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; T5UGO; mApple (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P33967; B.cereus Bsr.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
RX   PubMed=38244534; DOI=10.1016/j.scr.2024.103312;
RA   Miellet S., St Clair-Glover M., Maddock M., Dottori M.;
RT   "Generation of a gene-edited H9 embryonic stem cell line carrying a
RT   DOX-inducible NGN2 expression cassette in the CLYBL locus.";
RL   Stem Cell Res. 75:103312-103312(2024).
//